Open AccessLate-Breaking Abstract #1: Nilotinib Found Better than Imatinib for Patients with Newly Diagnosed CML in Chronic Phase
Author(s) -
Mark L. Fuerst
Publication year - 2010
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000368423.20055.47
Subject(s) - nilotinib , imatinib , medicine , oncology , myeloid leukemia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom